Navigation Links
Honorees of the Prestigious 2019 Blavatnik Regional Awards for Young Scientists Announced

The Blavatnik Family Foundation and the New York Academy of Sciences announced today the three Winners and six Finalists of the 2019 Blavatnik Regional Awards for Young Scientists. Supporting outstanding postdoctoral scientists from academic research institutions across New York, New Jersey, and Connecticut since 2007, the Blavatnik Regional Awards recognize outstanding researchers in three scientific disciplinary categories: Life Sciences, Physical Sciences & Engineering, and Chemistry. One Winner in each category is awarded $30,000 in unrestricted funds; two Finalists in each category receive $10,000 each in unrestricted funds.

In 2019, the Blavatnik Regional Awards received 137 nominations from 20 academic institutions in the tri-state area. The 2019 Blavatnik Regional Awards Winners are:

  • Life Sciences: Laura Duvall, PhD, nominated by The Rockefeller University (now at Columbia University). Dr. Duvall’s discovery of two key molecules in mosquitos that inhibit blood-feeding and breeding has worldwide implications for controlling mosquito populations and the spread of diseases such as Dengue and Zika. At the time of nomination, Dr. Duvall was a trainee of the 2007 Blavatnik Regional Awards Faculty Winner, Prof. Leslie Vosshall of The Rockefeller University.
  • Physical Sciences & Engineering: Netta Engelhardt, PhD, nominated by Princeton University (now at Massachusetts Institute of Technology). Dr. Engelhardt’s research at the interface of general relativity and quantum field theory is answering complex questions about the fundamentals of our universe, including the remarkable explanation for the origin of black hole entropy. Her work strives to understand how the fabric of the universe at large-scale is encoded in quantum gravity.
  • Chemistry: Juntao Ye, PhD, nominated by Cornell University (now at Shanghai Jiao Tong University in China). Improving synthetic efficiency while lowering the cost of synthesis is a primary goal for pharmaceutical industries. Dr. Ye invented several new methods that allow for converting readily available chemicals into value-added and pharmaceutically relevant products in a highly efficient and economical manner, while reducing chemical byproduct waste. These methods could improve the efficiency of synthesizing complex and bioactive compounds, thereby accelerating the pace of drug discovery.

In recognition of the outstanding achievements of the 2019 Blavatnik Regional Awards honorees, Len Blavatnik, Founder and Chairman of Access Industries and the Blavatnik Family Foundation, and member of the President’s Council of the New York Academy of Sciences stated, “These remarkable young scientists are making important contributions to scientific research and discovery early in their careers. We hope that the recognition this Award provides will both encourage and assist these brilliant young scientists as they pursue their innovative work to find solutions to mankind’s most challenging problems.”

“The cutting-edge discoveries being recognized this year cover an incredibly disparate breadth of work in quantum gravity, drug discovery, control of mosquito populations and underwater photographic imagery. These are the advances that will change our world,” said Ellis Rubinstein, President and CEO of the New York Academy of Sciences and chair of the Blavatnik Awards’ Scientific Advisory Council. “The creativity, passion and dedication of these rising stars in science is an inspiration.”

2019 Blavatnik Regional Awards Finalists
The following postdoctoral researchers have been named Finalists in their respective categories:

Life Sciences

  • Carla Nasca, PhD, nominated by The Rockefeller University -- recognized for the discovery of acetyl-L-carnitine (LAC) as a novel modulator of brain rewiring and a possible new treatment for depression that acts by turning on and off specific genes related to the neurotransmitter glutamate.
  • Liling Wan, PhD, nominated by The Rockefeller University (currently transitioning to the University of Pennsylvania) -- recognized for identifying a previously unknown function of a protein called ENL, which has the ability to read epigenetic information on our chromosomes and activate genes that perpetuate tumor growth. Elucidating the structure and mechanism of ENL has guided ongoing development of drugs to treat cancers.

Physical Sciences & Engineering

  • Derya Akkaynak, PhD, nominated by Princeton University -- recognized for significant breakthroughs in computer vision and underwater imaging technologies, resolving a fundamental technological problem in the computer vision community — the reconstruction of lost colors and contrast in underwater photographic imagery — which will have real implications for oceanographic research.
  • Matthew Yankowitz, PhD, nominated by Columbia University (now at the University of Washington) -- recognized for groundbreaking experimental work modifying the electronic properties of a new class of two-dimensional materials, known as van der Waal materials. van der Waal materials have garnered tremendous interest due to their incredible electronic properties and the promise they show for use in next-generation optoelectronic and electronic devices, future computing, and telecommunications technologies. Dr. Yankowitz’s work has led to the discovery that applied pressure can be used to induce superconductive properties in multi-layer graphene, and has significantly advanced a new area of research recently coined “twistronics.”


  • Yaping Zang, PhD, nominated by Columbia University -- recognized for innovatively using electrochemistry and electrical fields in conjunction with scanning tunneling microscopy techniques to drive chemical reactions. This work provides a deeper understanding of the reaction mechanisms and opens new avenues for the use of electricity as a catalyst in chemical reactions.
  • Igor Dikiy, PhD, nominated by the Advanced Science Research Center at The Graduate Center, CUNY -- recognized for completing the first study of G-protein–coupled receptor (GPCR) fast sidechain dynamics using NMR (nuclear magnetic resonance) spectroscopy to shed light on the molecular mechanisms of cell signaling. GPCRs control a variety of processes in the human body and are targets for over 30% of all FDA-approved drugs. Elucidating the mechanisms of GPCR signaling will enable researchers to design more effective drugs.

Honoring the Blavatnik Regional Award Winners and Finalists
The 2019 Blavatnik Regional Awards Winners and Finalists will be honored at the New York Academy of Sciences’ Annual Gala at Cipriani 25 Broadway in New York on Monday, November 11, 2019.

About the Blavatnik Family Foundation
The Blavatnik Family Foundation is an active supporter of world-renowned educational, scientific, cultural, and charitable institutions in the United States, the United Kingdom, Israel, and throughout the world. The Foundation is headed by Len Blavatnik, a global industrialist and philanthropist and the Founder and Chairman of Access Industries, a privately held U.S. industrial group with global strategic interests in natural resources and chemicals, media and telecommunications, real estate, and venture capital. See more at

About The New York Academy of Sciences
The New York Academy of Sciences is an independent, not-for-profit organization that since 1817 has been committed to advancing science, technology, and society worldwide. With more than 20,000 Members in 100 countries around the world, the Academy is creating a global community of science for the benefit of humanity. The Academy's core mission is to advance scientific knowledge, positively impact the major global challenges of society with science-based solutions, and increase the number of scientifically informed individuals in society at large. Please visit us online at and follow us on Twitter at @NYASciences.

To follow the progress of the Blavatnik Awards, please visit or follow us on Facebook and Twitter (@BlavatnikAwards).

Read the full story at

Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved

Related biology technology :

1. DrugDev to Promote Adoption of Innovative Technologies to Advance Clinical Study Efficiency at Prestigious Pharma and Biotech Industry Conferences in Q4
2. ExcitePCR’s CEO, Lyle Probst, Invited to Join Prestigious BioWatch Panel During Two-Day Workshop Hosted by the National Academies of Science, Engineering and Medicine
3. BioPoint Earns Spot on Prestigious Inc. 5000 List of Fastest-Growing Private Companies for Third Straight Year
4. Foundation for Food and Agriculture Research Congratulates Edward Buckler, First Recipient of Prestigious NAS Prize for Extraordinary Contribution to Food and Agriculture
5. Cognition Therapeutics Receives Prestigious Luis Villalobos Award from Angel Capital Association
6. Point-of-care Hematology Company Norma Instruments Receives Prestigious Millennium Innovation Prize
7. Prestigious Hertz Foundation Fellowship Recipients Announced
8. ASGCT Presidential Symposium to Feature Laureates of the Prestigious 2015 Japan Prize
9. ProMIS Neurosciences Announces Formation of Prestigious Scientific Advisory and Business Advisory Boards
10. Noblis CEO to Present Industry Keynote at Prestigious CES Government Conference
11. Flexpoint Sensor Systems, Inc. Partner Receives Prestigious Award at 2016 CES Innovation Awards
Post Your Comments:
(Date:10/10/2019)... ... October 10, 2019 , ... ... of clinical research centers in Europe. All Pratia research centers have completed VirTrial’s ... become trained and certified as Virtual Trial Capable and prepared to conduct decentralized ...
(Date:10/8/2019)... ... October 07, 2019 , ... Erchonia Corporation, the ... (“3LT®”), today announces that the U.S. Food and Drug Administration (FDA) has granted ... the temporary relief of chronic neck and shoulder pain of musculoskeletal origin. , ...
(Date:10/3/2019)... ... October 01, 2019 , ... ... reset itself, announced the midway point of its randomized research trial for individuals ... is to measure the efficacy of a non-invasive technology which compares tones delivered ...
(Date:10/3/2019)... ... October 02, 2019 , ... Today marked the official launch ... clinical program outsourcing success by cultivating radical improvements in leadership, staff, and broader ... Brenda Reese, phaseUP™ brings clients deep, broad and unique expertise in the intricacies ...
Breaking Biology Technology:
(Date:11/14/2019)... ... , ... Personalized Stem Cells, Inc (“PSC”), a human adipose-derived stem ... trial for stem cell treatment of knee osteoarthritis . The first treatment came shortly ... VetStem Biopharma. , In July of 2019, PSC received FDA approval for ...
(Date:11/12/2019)... ... 2019 , ... The Arnold and Mabel Beckman Foundation today ... for its Instrumentation Grant for Advanced Light-Sheet Microscopy and Data Science . ... the acquisition of instrumentation, development and maintenance; support for data science collaborations within ...
(Date:11/9/2019)... ... November 08, 2019 , ... StageBio ... histology, pathology, biomarker development, and archiving services for the biopharmaceutical, medical device ... Histo-Scientific Research Laboratories (HSRL), Vet Path Services (VPS) and Tox Path Specialists ...
Breaking Biology News(10 mins):